Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TATE.L Stock Summary
Top 10 Correlated ETFs
TATE.L
In the News
TATE.L Financial details
Company Rating
Strong Buy
Market Cap
2.39B
Income
426M
Revenue
3.33B
Book val./share
3.04
Cash/share
0.98
Dividend
0.19
Dividend %
3.03%
Employees
3.6K
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
195.65
Forward P/E
1187.5
PEG
24.56
P/S
3.69
P/B
2.14
P/C
630.1
P/FCF
-112.77
Quick Ratio
0.83
Current Ratio
2.24
Debt / Equity
0.49
LT Debt / Equity
0.46
-
-
EPS (TTM)
1.06
EPS next Y
0.52
EPS next Q
-
EPS this Y
-20.34%
EPS next Y
-51.4%
EPS next 5Y
-35.51%
EPS last 5Y
0.43%
Revenue last 5Y
-8.67%
Revenue Q/Q
-4.99%
EPS Q/Q
52.94%
-
-
-
-
SMA20
-0.33%
SMA50
-3.2%
SMA100
-4.12%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.07%
Gross Margin
37%
Oper. Margin
20%
Profit Margin
2%
Payout
554%
Shs Outstand
397.7M
Shs Float
388.88M
-
-
-
-
Target Price
-
52W Range
587.0-837.5
52W High
-26.22%
52W Low
+5.2%
RSI
63
Rel Volume
0.44
Avg Volume
1.5M
Volume
659.9K
Perf Week
2.4%
Perf Month
-0.16%
Perf Quarter
-7.7%
Perf Half Y
-9.59%
-
-
-
-
Beta
0.489
-
-
Volatility
8.64%, 8.45%
Prev Close
-0.4%
Price
617.5
Change
0.24%
TATE.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.95 | 7.24 | 3.04 | 3.45 | 4.33 | |
Net income per share | 0.46 | 0.62 | 0.64 | 0.59 | 0.47 | |
Operating cash flow per share | 0.83 | 1.07 | 0.94 | 0.34 | 0.29 | |
Free cash flow per share | 0.57 | 0.65 | 0.56 | -0.03 | 0.1 | |
Cash per share | 0.73 | 0.85 | 1.01 | 0.28 | 1.18 | |
Book value per share | 3.76 | 3.52 | 3.65 | 4.06 | 2.94 | |
Tangible book value per share | 2.89 | 2.15 | 2.21 | 2.84 | 1.06 | |
Share holders equity per share | 3.76 | 3.52 | 3.65 | 4.06 | 2.94 | |
Interest debt per share | 1.56 | 1.54 | 1.74 | 1.64 | 1.73 | |
Market cap | 3.34B | 3.05B | 3.56B | 3.41B | 3.17B | |
Enterprise value | 3.65B | 3.5B | 3.98B | 3.97B | 3.41B | |
P/E ratio | 18.43 | 12.43 | 14.08 | 14.43 | 16.69 | |
Price to sales ratio | 1.21 | 1.06 | 2.94 | 2.48 | 1.81 | |
POCF ratio | 10.11 | 7.17 | 9.52 | 24.86 | 26.87 | |
PFCF ratio | 14.7 | 11.76 | 16.04 | -309.59 | 79.26 | |
P/B Ratio | 2.24 | 2.18 | 2.45 | 2.1 | 2.67 | |
PTB ratio | 2.24 | 2.18 | 2.45 | 2.1 | 2.67 | |
EV to sales | 1.32 | 1.21 | 3.29 | 2.89 | 1.95 | |
Enterprise value over EBITDA | 8.14 | 7.15 | 15.66 | 16.16 | 10.62 | |
EV to operating cash flow | 11.06 | 8.23 | 10.64 | 29.01 | 28.89 | |
EV to free cash flow | 16.07 | 13.5 | 17.92 | -361.31 | 85.21 | |
Earnings yield | 0.05 | 0.08 | 0.07 | 0.07 | 0.06 | |
Free cash flow yield | 0.07 | 0.09 | 0.06 | 0 | 0.01 | |
Debt to equity | 0.39 | 0.42 | 0.46 | 0.39 | 0.56 | |
Debt to assets | 0.21 | 0.2 | 0.23 | 0.19 | 0.27 | |
Net debt to EBITDA | 0.7 | 0.92 | 1.64 | 2.31 | 0.74 | |
Current ratio | 1.61 | 2.23 | 2.34 | 3.06 | 2.24 | |
Interest coverage | 9.55 | 9.61 | 7.14 | 7.22 | 7.79 | |
Income quality | 1.82 | 1.73 | 4.2 | 5.27 | 0.93 | |
Dividend Yield | 0.04 | 0.04 | 0.04 | 0.04 | 0.18 | |
Payout ratio | 0.74 | 0.56 | 0.54 | 0.61 | 3 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.12 | 0.19 | 0.19 | 0.15 | 0.3 | |
Capex to operating cash flow | -0.31 | -0.39 | -0.41 | -1.08 | -0.66 | |
Capex to revenue | -0.04 | -0.06 | -0.13 | -0.11 | -0.04 | |
Capex to depreciation | -0.68 | -0.97 | -1.57 | -1.85 | -0.82 | |
Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Graham number | 6.21 | 6.98 | 7.23 | 7.35 | 5.58 | |
ROIC | 0.11 | 0.12 | 0.07 | 0.04 | 0.1 | |
Return on tangible assets | 0.07 | 0.11 | 0.11 | 0.09 | 0.11 | |
Graham Net | -1.46 | -1.6 | -1.47 | -2.88 | -0.86 | |
Working capital | 415M | 624M | 745M | 1.61B | 712M | |
Tangible asset value | 1.15B | 857M | 881M | 1.13B | 430M | |
Net current asset value | -208M | -320M | -211M | 758M | -33M | |
Invested capital | 0.39 | 0.42 | 0.46 | 0.39 | 0.56 | |
Average receivables | 278.5M | 311M | 337.5M | 312.5M | 320.5M | |
Average payables | 213M | 242M | 258.5M | 209M | 200.5M | |
Average inventory | 426.5M | 445M | 494M | 424.5M | 381.5M | |
Days sales outstanding | 38.55 | 41.92 | 103.68 | 74.59 | 75.04 | |
Days payables outstanding | 56.26 | 45.85 | 107.33 | 53.2 | 72.71 | |
Days of inventory on hand | 104.35 | 83.64 | 213.85 | 111.68 | 129.71 | |
Receivables turnover | 9.47 | 8.71 | 3.52 | 4.89 | 4.86 | |
Payables turnover | 6.49 | 7.96 | 3.4 | 6.86 | 5.02 | |
Inventory turnover | 3.5 | 4.36 | 1.71 | 3.27 | 2.81 | |
ROE | 0.12 | 0.18 | 0.17 | 0.15 | 0.16 | |
Capex per share | -0.26 | -0.42 | -0.38 | -0.37 | -0.19 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.65 | 1.81 | 2.07 | 2.27 | 2.15 | |
Net income per share | 0.26 | 0.34 | 0.29 | 0.17 | 0.26 | |
Operating cash flow per share | 0.51 | -0.17 | 0.13 | 0.16 | 0.27 | |
Free cash flow per share | 0.34 | -0.37 | 0.05 | 0.05 | 0.16 | |
Cash per share | 0.97 | 0.28 | 1.26 | 1.19 | 0.98 | |
Book value per share | 3.78 | 4.07 | 2.97 | 2.99 | 3.04 | |
Tangible book value per share | 3.05 | 2.85 | 1.76 | 1.08 | 1.96 | |
Share holders equity per share | 3.78 | 4.07 | 2.97 | 2.99 | 3.04 | |
Interest debt per share | 1.72 | 1.62 | 1.85 | 1.73 | 1.53 | |
Market cap | 3.22B | 3.4B | 2.79B | 3.12B | 2.73B | |
Enterprise value | 3.56B | 3.97B | 3.07B | 3.36B | 2.98B | |
P/E ratio | 7.89 | 6.34 | 5.77 | 11.3 | 6.69 | |
Price to sales ratio | 4.91 | 4.73 | 3.29 | 3.46 | 3.19 | |
POCF ratio | 15.78 | -50.76 | 52.67 | 48 | 25.04 | |
PFCF ratio | 23.49 | -22.98 | 139.57 | 156.01 | 43.33 | |
P/B Ratio | 2.14 | 2.1 | 2.29 | 2.62 | 2.26 | |
PTB ratio | 2.14 | 2.1 | 2.29 | 2.62 | 2.26 | |
EV to sales | 5.42 | 5.52 | 3.62 | 3.72 | 3.48 | |
Enterprise value over EBITDA | 37.84 | 74.9 | 19.08 | 25.83 | 17.52 | |
EV to operating cash flow | 17.44 | -59.25 | 57.97 | 51.66 | 27.33 | |
EV to free cash flow | 25.97 | -26.82 | 153.62 | 167.91 | 47.28 | |
Earnings yield | 0.03 | 0.04 | 0.04 | 0.02 | 0.04 | |
Free cash flow yield | 0.04 | -0.04 | 0.01 | 0.01 | 0.02 | |
Debt to equity | 0.45 | 0.39 | 0.61 | 0.56 | 0.49 | |
Debt to assets | 0.22 | 0.19 | 0.27 | 0.27 | 0.26 | |
Net debt to EBITDA | 3.61 | 10.74 | 1.75 | 1.83 | 1.46 | |
Current ratio | 3.21 | 3.06 | 2.64 | 2.24 | 2.88 | |
Interest coverage | 2.75 | 2.43 | 7.6 | 4.82 | 9.46 | |
Income quality | 17 | -4.79 | 0.95 | 0.92 | 1.07 | |
Dividend Yield | 0.03 | 0.01 | 0.2 | 0.01 | 0.02 | |
Payout ratio | 1 | 0.31 | 4.53 | 0.32 | 0.51 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.15 | 0.18 | 0.3 | 0.18 | |
Capex to operating cash flow | -0.33 | 1.21 | -0.62 | -0.69 | -0.42 | |
Capex to revenue | -0.1 | -0.11 | -0.04 | -0.05 | -0.05 | |
Capex to depreciation | -1.1 | -4.26 | -0.7 | -0.94 | -0.98 | |
Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Graham number | 4.66 | 5.55 | 4.44 | 3.42 | 4.18 | |
ROIC | 0.01 | 0.01 | 0.05 | 0.04 | 0.05 | |
Return on tangible assets | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | |
Graham Net | -2.25 | -2.89 | -1.08 | -0.88 | -0.75 | |
Working capital | 629M | 1.61B | 862M | 712M | 721M | |
Tangible asset value | 1.22B | 1.13B | 724M | 430M | 780M | |
Net current asset value | -697M | 758M | -103M | -33M | -16M | |
Invested capital | 0.45 | 0.39 | 0.61 | 0.56 | 0.49 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 35.95 | 35.17 | 43.78 | 35.92 | 31.82 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.5 | 2.56 | 2.06 | 2.51 | 2.83 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.07 | 0.08 | 0.1 | 0.06 | 0.08 | |
Capex per share | -0.17 | -0.2 | -0.08 | -0.11 | -0.12 |
TATE.L Frequently Asked Questions
What is Tate & Lyle plc stock symbol ?
Tate & Lyle plc is a GB stock and trading under the symbol TATE.L
What is Tate & Lyle plc stock quote today ?
Tate & Lyle plc stock price is $617.5 today.
Is Tate & Lyle plc stock public?
Yes, Tate & Lyle plc is a publicly traded company.